WST

West Pharmaceutical Services, Inc.

Ten-year history of valuation, safety, growth and profitability, with percentile bands against WST’s own range.

Snapshot

P/E

41.4×

P97

Yield

0.2%

P39

FCF payout

14.3%

Net debt / EBITDA

-0.69

P67

DGR 5y

5.4%

P14

ROIC

4.3%

P59

Value

Is the share cheap or dear by its own history?

WST is historically expensive. P/E at P97 (41.4x); yield at P39 (0.2%).

Safety

Can the business comfortably cover the dividend?

FCF payout sits at P6 (14%) of its history. Leverage (Net Debt/EBITDA) at P67 (-0.69); interest cover at P0 (0.00).

Growth

Is the dividend and the cash behind it still growing?

5-year dividend growth at P14 (5%) of its 10y range. FCF growth P43 (27%); ROIC P59 (4%).

Profitability

Is the engine getting better or worse at making money?

Gross margin at P53 (37%) of its history. Operating margin P57 (21%); net margin P57 (17%).

Forecast your income with the WST dividend calculator

Free account

Sign up free to look up 10 stocks a day.

Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.